Long-term effect of stent coating with zedoary essential components on neointimal formation in the porcine coronary artery

被引:0
作者
Fu-hai Zhao
Jian-gang Liu
Xin Wang
Da-wu Zhang
Pei-li Wang
Lei Zhang
Jian-peng Du
Xin-zhi Li
Yan-lei Ma
Yue Shi
Da-zhuo Shi
机构
[1] China Academy of Chinese Medical Sciences,Cardiovascular Center of Xiyuan Hospital
来源
Chinese Journal of Integrative Medicine | 2013年 / 19卷
关键词
zedoary essential component-eluting stent; restenosis; neointimal; endothelialization;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:771 / 776
页数:5
相关论文
共 71 条
  • [1] Cook S(2009)Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis Circulation 120 391-399
  • [2] Ladich E(2010)Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes. From the Western Denmark Heart Registry EuroIntervention 5 898-905
  • [3] Nakazawa G(2011)The targets of curcumin Curr Drug targets 12 332-347
  • [4] Eshtehardi P(2007)Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and antiproliferative responses through a ROS-independent mechanism Carcinogenesis 28 1765-1773
  • [5] Neidhart M(1992)Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model J Am Coll Cardiol 19 267-274
  • [6] Vogel R(2001)Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model Circulation 104 1183-1193
  • [7] Jensen LO(2008) comparison between optical coherence tomography and intravascular ultrasound for detecting small degrees of in-stent neointima after stent implantation J Am Coll Cardiol Interv 1 168-173
  • [8] Tilsted HH(2011)Anti-angiogenesis effect of essential oil from J Ethnopharmacol 133 220-226
  • [9] Thayssen P(2006) and Int J Cancer 119 757-764
  • [10] Kaltoft A(2008)Curcumin inhibits the mammalian target of rapamycin-mediated signaling pathways in cancer cells Br J Pharmacol 153 557-567